Printer Friendly

How much "UFC" is really cortisol?

When urinary free cortisol (UFC) determinations became readily available for clinical use in 1968 (1), chromatographic methods were cumbersome. The first competitive protein-binding method (radiotransinassay) (1) used human corticosteroid-binding globulin (transcortin) as the binding protein. The specificity of the assay was enhanced by the use of Fuller's earth as the agent to adsorb the unbound fraction because it takes up some of the competing steroids differentially (2). The reference interval was -10-100 Ag/day (30-300 nmol/day).

When radioimmunoassays, based on the same competitive binding principle but using antibodies raised to cortisol linked to albumin, became popular during the 1970s, it was assumed that these would be more specific for cortisol, but this assumption was not warranted. As pointed out recently (3), most of the articles published over the past 20 years have quoted even higher values, reflecting a significant lack of specificity.

In 1976, Chattoraj et al. (4) found values for UFC after combined thin-layer and column chromatography that were approximately one-half those of the original method (1), as did Schoneshofer et al. in 1980 (5) after HPLC, and Murphy et al. in 1981 (6) after Sephadex LH-20 chromatography.

The last group (6) showed that of four commercial antibodies tested in samples from 20 patients, including patients with Cushing syndrome, obesity, and pregnancy, two appeared to be much less specific than the three transcortins (human, dog, and horse). One of the antibodies gave values four- to fivefold higher, but preliminary chromatography was recommended, which lowered the values to close to the transcortin values. None of the antibodies gave values substantially lower than the transcortins. Whereas the transcortins all gave values that correlated well with each other (r [greater than or equal to]0.90), two of the antibodies gave consistently higher values in pregnancy.

The situation for the determination of cortisol in cord blood at delivery was similar: some antibodies gave extremely high values-up to 10-fold higher than the values after chromatography (7). As pointed out by Murphy in 1983 (7), cord blood contains many steroids that are not present in adult blood.

Although it has been apparent for more than 20 years that many antibodies give falsely high values for cortisol, especially for "UFC", this fact seems to have been systematically ignored. Only a few authors have bothered to validate their methods, although HPLC has been readily available during this period. Although some of the methods used seem to correlate well with the true values (8) and have demonstrated their clinical utility, is this good enough? Although such methods have been useful for the detection of Cushing syndrome, low values cannot be interpreted. Few commercial suppliers actually give normal means and ranges for UFC. Their specificity data are not very helpful because much of the competing material has not been identified and varies from one batch of antibody to another, even by the same supplier.

If it is assumed, and it usually is, that the unidentified material consists of cortisol metabolites, does it really matter? Yes, it may be very important because this assumption requires that the [metabolism.bar] of the cortisol must be normal--an assumption that is unwarranted and is rarely tested.

Demitrack et al. in 1991 (9) provided evidence that patients with chronic fatigue syndrome have lower values of UFC than healthy subjects. Their values in healthy subjects had a mean of 200 nmol/day with a range from ~100 to 300 nmol/day, approximately threefold higher than the "true" mean excretion rate of 57 nmol/day, with a range of 28-117 nmol/day, that had been established by Schoneshofer et al. (5) using HPLC. Their patients with chronic fatigue syndrome had a mean excretion rate of 125 (range, 70-200) nmol/day, i.e., considerably higher than the values established with more nearly accurate methods but lower than in the control subjects studied with their method. So what do the lower "UFC" values in the chronic fatigue syndrome patients really mean? Such patients do not have true adrenal insufficiency as determined by adrenocorticotropic hormone or insulin hypoglycemia testing, and have been considered to have "central" adrenal insufficiency. However, because less than one-half of the "UFC" is really cortisol, interpretation of these results is impossible. Rather than low cortisol, might it not be some metabolite that is present in lesser quantities in the patients compared with the controls? And might this not reflect a difference in the way cortisol is handled by these patients?

The same considerations apply to the interpretation of the results of Putignano et al. (10) in this issue. Because only approximately one-half of the material is cortisol (range, 16-88 /,g/day or 44-244 nmol/day), it is difficult to interpret the results. We must assume that the unidentified material behaves the same as cortisol at all rates of water excretion, which may or may not be true. Their results differ from those of Mericq and Cutler in 1998 (11), whose values were approximately four times the true values. As the authors themselves point out, further studies using chromatographic methods are needed to resolve this issue.

After more than 20 years since the true values for UFC were established, it is time we stopped using such inaccurate methodology and terminology with respect to "urinary free cortisol".

References

(1.) Murphy BEP. Clinical evaluation of urinary cortisol determinations by competitive protein-binding radioassay. J Clin Endocrinol Metab 1968;28: 343-8.

(2.) Murphy BEP. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab 1967;27:973-90.

(3.) Murphy BEP. Lack of specificity of urinary free cortisol determinations: why does it continue? J Clin Endocrinol Metab 1999;83:2258-9.

(4.) Chattoraj SC, Turner AK, Pinkus JL, Charles D. The significance of urinary free cortisol and progesterone in normal and anencephalic pregnancy. Am J Obstet Gynecol 1976;124:848-54.

(5.) Schoneshofer M, Fenner A, Dulce HJ. Interferences in the radioimmunological determination of urinary free cortisol. Clin Chim Acta 1980;106: 63-73.

(6.) Murphy BEP, Okouneff L, Klein GP, Ngo SC. Lack of specificity of cortisol determinations in human urine. J Clin Endocrinol Metab 1981;53:91-9.

(7.) Murphy BEP. Human fetal serum cortisol levels at delivery: a review. Endocr Rev 1983;4:150-4.

(8.) Lin C-L, Wu T-J, Machacek DA, Jiang N-S. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1997;82:151-5.

(9.) Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73: 1224-34.

(10.) Putignano P, Dubini A, Cavagnini F. Urinary free cortisol is unrelated to physiological changes in urine volume in healthy women [Letter]. Clin Chem 2000;46:879.

(11.) Mericq MV, Cutler GB Jr. High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab 1998;83:682-4.

Beverley E. Pearson Murphy

Montreal General Hospital

1650 Cedar, Room C6260

Montreal, Quebec H3G 1A4, Canada
COPYRIGHT 2000 American Association for Clinical Chemistry, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Editorial
Author:Murphy, Beverley E. Pearson
Publication:Clinical Chemistry
Date:Jun 1, 2000
Words:1181
Previous Article:Microchip-Based Assay Systems: Methods and Applications.
Next Article:Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.
Topics:


Related Articles
Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol.
Urinary free cortisol is unrelated to physiological changes in urine volume in healthy women.
Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone.
Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment.
New enzyme immunoassay for salivary cortisol.
Urinary free cortisol is not affected by short-term water diuresis.
Determination of urinary free cortisol by HPLC.
Specific determination of urinary free cortisol by solid-phase microparticle extraction capillary electrophoresis with fused silica capillaries.
How much "urinary free cortisol" is really cortisol during water diuresis in healthy individuals?

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters